Literature DB >> 172224

Inhibition of replication of virus-transformed fibroblasts by antibodies to RNA.

L Varesio, P Cappuccinelli, G Forni.   

Abstract

The activity of 7S immunoglobulins (Ig) antibody to RNA, obtained in rabbits after a prolonged immunization with RNA-methylated bovine serum albumin complex was evaluated in vitro on normal (3T3) and simian virus 40-transformed (SV 3T3) mouse fibroblasts. The presence of anti-RNA antibody in the culture medium inhibited both the SV 3T3 cell proliferation and the [3H]thymidine incorporation. In contrast, an increased [3H]uridine incorporation was evident within 48 and 96 hr of culture. No significant modification in these 3 parameters was observed in 3T3 cultures treated in the same manner. Both 3T3 and SV 3T3 showed cytoplasmic fluorescence when cultured in the presence of fluoresceinated anti-RNA Ig. However, with the indirect fluorescence technique anti-RNA Ig were detected in SV 3T3 cytoplasm only. These data suggest that anti-RNA Ig were taken up by both 3T3 and SV 3T3, but only in SV 3T3 did the anti-RNA Ig retain their antigenic properties and block cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172224

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Intracellular modifications induced in mouse submaxillary glands by antibodies directed against saliva.

Authors:  J C Weill; M Goldberg
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

2.  Antibody penetration into living cells. I. Intranuclear immunoglobulin in peripheral blood mononuclear cells in mixed connective tissue disease and systemic lupus erythematosus.

Authors:  D Alarcón-Segovia; A Ruíz-Argüelles; E Fishbein
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

3.  Inhibition of adenovirus DNA synthesis in vitro by sera from patients with systemic lupus erythematosus.

Authors:  M S Horwitz; B R Friefeld; H D Keiser
Journal:  Mol Cell Biol       Date:  1982-12       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.